Difference between injection plain ropivacaine with injection ropivacaine and injection tramadol under spinal anaesthesia in patients for vaginal hysterectomy

A Comparative Evaluation Of Plain Hyperbaric Ropivacaine Versus Hyperbaric Ropivacaine With Tramadol Under Spinal Anaesthesia In Patients Undergoing Vaginal Hysterectomy - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059932

Enrollment

Registered

2023-11-17

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system

Interventions

Intervention1: Spinal: spinal Intervention2: Ropivacaine 0.75%(H): Patient undergoing vaginal hysterectomy will be divided into Group R. Group R will receive spinal anaesthesia with injection Ropivaca

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA 1 and 2 female patients. 2. Patients aged between 40 to 60 years. 3. Patients undergoing vaginal hysterectomy under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: 1. Patient refusal. 2. Patient history of allergy to opioids or local anaesthetic. 3. Patient with bleeding tendencies(due to either primary disease or use of anticoagulant) 4. Patient with neurological disorder. 5. Patient with spine abnormalities. 6. Morbidly obese patients. 7. Local site infection.

Design outcomes

Primary

Measure	Time frame
To assess the duration analgesia using Ropivacaine (0.75%) and Ropivacaine (0.75%) with Tramadol 25mg in spinal anaesthesia in patient udergoing vaginal hysterectomy.Timepoint: To study the duration analgesia at 0 min,30 mins,1,2,4,6,8,16,24 hours in the post operative period .	—

Secondary

Measure	Time frame
1. To evaluate the time of onset of sensory and motor blockade. 2. Time of regression of segments of sensory blockade. 3. Time of regression of motor blockade. 4. Hemodynamic response. 5. Adverse effects. 6. Number of doses of recue analgesia required and time for first analgesic request.Timepoint: First24hours monitoring.	—

Countries

India

Contacts

Public ContactDr Karthik G S

Rajarajeswari Medical College and Hospital

drgskarthik@gmail.com9538220515

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026